The treatment, called Aucatzyl, has been granted marketing approval for the treatment of adult patients with relapsed or refractory B-cell precursor ALL, the London biopharmaceutical company said ...

Multi-channel marketing is becoming more established in the pharmaceutical industry, with the sector supplementing its traditional face-to-face sales and marketing contacts with a wide variety of ...

Manroop Takhar explores how animation is shaping pharmaceutical marketing in his article, by discussing the history of animation and its relationship with marketing. Once upon a time, medicine and ...

Source: Getty Images. The Agency 100 is MM+M’s annual ranking of the industry’s top healthcare marketing firms, based on North American revenue. Art by Seth Abel. The first MM+M/Publicis Health Pharma ...

What is Pharma 4.0? The term Industry 4.0 refers to the fourth industrial revolution, associated with the application of advanced technologies that have dramatically changed the landscape of ...

However, as counterintuitive as it may seem, those in the marketing and commercial ranks say the industry has yet to make major gains on the digital transformation front. Data from the second annual ...

Fierce’s Rebecca Willumson sat down with Swoop President Scott Rines – live at Digital Pharma East – to discuss some of the most pressing issues in pharma marketing today. Rines kicks off by ...

What trends in life sciences are influencing marketing and media? For Lea Wester, Managing Director at Addressable Health, the spotlight is on precision medicine. “The FDA defines precision ...

Lundbeck A/S (Lundbeck) and Longboard Pharmaceuticals ... is an investigational compound that is not approved for marketing by the FDA or any other regulatory authority. About H.

October 14, 2024--(BUSINESS WIRE)--H. Lundbeck A/S (Lundbeck) and Longboard Pharmaceuticals, Inc (NASDAQ: LBPH) (Longboard) today announced an agreement for Lundbeck to acquire Longboard.